Morgan Stanley Sensus Healthcare, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Morgan Stanley holds 195,304 shares of SRTS stock, worth $943,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares

195,304

Previous 249,306 21.66%

Holding current value

$943,318

Previous $1.71 Million 45.93%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$4.35 - $8.99 $234,908 - $485,477	-54,002 Reduced 21.66%	195,304 $923,000
Q4 2024 Feb 14, 2025	BUY	$5.95 - $8.95 $381,026 - $573,140	64,038 Added 34.57%	249,306 $1.71 Million
Q3 2024 May 14, 2025	BUY	$4.93 - $7.05 $734,708 - $1.05 Million	149,028 Added 411.23%	185,268 $1.07 Million
Q3 2024 Nov 14, 2024	BUY	$4.93 - $7.05 $734,708 - $1.05 Million	149,028 Added 411.23%	185,268 $1.07 Million
Q2 2024 May 14, 2025	SELL	$3.14 - $6.42 $669,027 - $1.37 Million	-213,066 Reduced 85.46%	36,240 $193,000
Q2 2024 Oct 17, 2024	BUY	$3.14 - $6.42 $102,407 - $209,381	32,614 Added 899.45%	36,240 $193,000
Q2 2024 Aug 14, 2024	BUY	$3.14 - $6.42 $102,407 - $209,381	32,614 Added 899.45%	36,240 $193,000
Q1 2024 Oct 17, 2024	SELL	$2.49 - $4.91 $81,208 - $160,134	-32,614 Reduced 89.99%	3,626 $13,000
Q1 2024 Aug 16, 2024	BUY	$2.49 - $4.91 $1,558 - $3,073	626 Added 20.87%	3,626 $13,000
Q1 2024 May 15, 2024	BUY	$2.49 - $4.91 $1,558 - $3,073	626 Added 20.87%	3,626 $13,000
Q4 2023 Aug 16, 2024	SELL	$1.87 - $2.71 $62,158 - $90,080	-33,240 Reduced 91.72%	3,000 $7,000
Q4 2023 Feb 13, 2024	SELL	$1.87 - $2.71 $7,839 - $11,360	-4,192 Reduced 58.29%	3,000 $7,000
Q3 2023 Nov 15, 2023	SELL	$2.62 - $3.91 $7,105 - $10,603	-2,712 Reduced 27.38%	7,192 $19,000
Q2 2023 Aug 14, 2023	BUY	$2.62 - $5.28 $14,865 - $29,958	5,674 Added 134.14%	9,904 $31,000
Q1 2023 May 15, 2023	BUY	$4.9 - $9.49 $6,487 - $12,564	1,324 Added 45.56%	4,230 $22,000
Q4 2022 Feb 14, 2023	SELL	$5.91 - $14.28 $1.96 Million - $4.75 Million	-332,363 Reduced 99.13%	2,906 $21,000
Q3 2022 Nov 14, 2022	BUY	$7.64 - $14.97 $819,856 - $1.61 Million	107,311 Added 47.07%	335,269 $4.2 Million
Q2 2022 Oct 27, 2022	BUY	$7.06 - $11.37 $1.6 Million - $2.58 Million	226,567 Added 16288.07%	227,958 $1.75 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $11.37 $1.6 Million - $2.58 Million	226,567 Added 16288.07%	227,958 $1.75 Million
Q1 2022 Oct 27, 2022	SELL	$6.83 - $11.84 $1.55 Million - $2.68 Million	-226,567 Reduced 99.39%	1,391 $14,000
Q1 2022 May 13, 2022	BUY	$6.83 - $11.84 $9,452 - $16,386	1,384 Added 19771.43%	1,391 $14,000
Q4 2021 Feb 14, 2022	SELL	$3.59 - $8.34 $36,574 - $84,967	-10,188 Reduced 99.93%	7 $0
Q3 2021 Nov 15, 2021	BUY	$3.22 - $4.09 $32,827 - $41,697	10,195 New	10,195 $37,000

Others Institutions Holding SRTS

# of Institutions

Shares Held

4.04M

Call Options Held

16.6K

Put Options Held

23.3K

View Full List

About Sensus Healthcare, Inc.

Ticker SRTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,556,000
Market Cap $80M
Description
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...

More about SRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account